The Vanta Bioscience IPO date has been confirmed to have started on September 25, 2017 and ended on September 27, 2017. Read the post to learn about Vanta Bioscience IPO GMP.
Using an IPO, Vanta Bioscience is seeking to raise Rs 7.56 crore. Its price is ₹50 per share and the minimum lot size for an application is 3000 shares. The minimum investment for retail investors is ₹150,000.
Start your investing journey today. Find the latest information on Upcoming IPOs.
Key Details Of Vanta Bioscience IPO:
Bidding Dates
September 25-27
Price Range
₹50 per share
Face Value
₹10 per share
GMP
₹47.14
Vanta Bioscience IPO GMP
The Vanta Bioscience Limited IPO GMP is ₹47.14.
Vanta Bioscience IPO Overview
Vanta Bioscience’s initial public offering (IPO) has a set price of Rs 7.56 crore. The IPO auction for Vanta Bioscience began on September 25, 2017 and ended on September 27, 2017. On October 6, 2017, the shares were listed on the BSE SME. The IPO price for Vanta Bioscience is $50 per share. The Vanta Bioscience Limited IPO GMP is ₹47.14. A lot size of 3000 shares is required for an application. Retail investors must make a minimum investment of $150,000 to participate.
VBL model provides the in vitro tests (cell, tissue, and organism) and in vivo activities (animal) that suit the client’s requirements worldwide and are all acceptable for various regulatory bodies globally. Toxicology is a science-based discipline concerned with the destructive capacity of the chemicals for life in every form. It is a life science which covers biology, chemistry, and pharmacology.It also investigates the adverse effects of chemical, biological, and physical agents in biological systems in order to determine the level of damage to living creatures.
In toxicology, the link between dose and its effects on the exposed organism is extremely important. Toxicology and risk assessment are very confused and are regarded as synonyms. The headquarters of Vanta Bioscience resides in Des Moines, IA, with offices in Brussels, BE, and W. Des Moines, IA. Chennai, India, is where Centro de Investigacion de Toxicology tests for the presence of toxic substances.
Vanta Bioscience IPO Details
| IPO Date | September 25, 2017 to September 27, 2017 |
| Listing Date | October 6, 2017 |
| Face Value | ₹10 per share |
| Price | ₹50 per share |
| Lot Size | 3000 Shares |
| Total Issue Size | 1,512,000 shares (aggregating up to ₹7.56 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | BSE SME |
Vanta Bioscience IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 3000 | ₹150,000 |
| Retail (Max) | 1 | 3000 | ₹150,000 |
Vanta Bioscience IPO Listing Details
| Listing Date | October 6, 2017 |
| BSE Script Code | 540729 |
| NSE Symbol | |
| ISIN | INE695X01011 |
| Final Issue Price | ₹50 per share |
Company Profile
Vanta Bioscience Ltd. (VBL), founded in 1995, is a preclinical contract research organisation that provides drug safety assessment services for pharmaceutical, medical devices and biotech companies in the areas of nutraceuticals, feed additives, cosmetics, chemicals, agrochemicals, and cosmetics. Lastly, they do risk assessments related to API, excipients, and extractable and leachable substance analysis, which can be contaminated in the production process or at the product degradation point.
VBL not only furnishes advice to the pharmaceutical producers on the ways to establish health-based exposure limits (e.g., permitted daily exposure (PDE) or allowed daily exposure (ADE), as well as occupational exposure limits (OEL)) but it also helps them in this regard. They offer toxicology, batch release studies, biocompatibility evaluation, chemical safety and feed composition.
Registrar Info
| Name | Bigshare Services Pvt Ltd |
| Phone number | +91-22-6263 8200 |
| Email ID | [email protected] |
| Website | ipo.bigshareonline.com |
Contact Details
| Name | Vanta Bioscience Ltd |
| Phone number | +91 40 6657 5454 |
| Email ID | [email protected] |
| Website | vantabio.com |
IPO Strengths
- Experienced promoters and a competent management team.
- Well-established relationships with a loyal customer base.
- Access to markets worldwide, enabling global reach.
IPO Weakness
- Heavy reliance on customers based in the United States.
- Need to adhere to multiple laws and regulations in these countries to ensure compliance.
- Competition from other players in the market.
Vanta Bioscience IPO FAQs
When Vanta Bioscience IPO will open?
The Vanta Bioscience IPO opens on September 25, 2017 and closes on September 27, 2017.
What is the lot size of Vanta Bioscience IPO?
Vanta Bioscience IPO lot size is 3000 Shares, and the minimum amount required is ₹150,000.
When is Vanta Bioscience IPO listing date?
The Vanta Bioscience IPO listing date is on October 6, 2017.
Leave a Reply